产品名称:Bevacizumab ( 贝伐珠单抗 );
产品编号:YR1001;
分子名称:Bevacizumab;
克隆性:Monoclonal;
产品别称:12-IgG1, F(ab)-12 IgG1;
关键词:Anti VEGF, bevacizumab, Anti-Human VEGF Therapeutic Antibody12-IgG1, F(ab)-12 IgG1, Fab-12 IgG1, rhuMAb-VEGF, Anti VEGF, bevacizumab, Bevacizumab, bevacizumab, 216974-75-3, DB00112VEGFA, vascular endothelial growth factor A, vascular endothelial growth factor , VEGF, VEGF A, VPF, vascular permeability factor, VEGF, MVCD1, MGC70609, Anti-Human VEGF Therapeutic Antibody, Bevacizumab, 贝伐珠单抗;
规格:1mg, 5mg;
浓度:1mg/ml;
抗体亚型:IgG1 Kappa;
宿主:;
CAS号:216974-75-3;
来源:CHO Cells;
纯度:≥95% as determined by SDS-PAGE;
缓冲体系:Supplied in PBS, PH7.5;
分子量:149000.00 Da;
产品背景:Bevacizumab, sold under the brand name Avastin, is a medication used to treat a number of types of cancers and a specific eye disease.;
保存条件:Stored at -20℃ to -80℃.;
运输条件:Shipped on ice packs.;
产品应用:FC, IP, ELISA, Neut, FuncS, IF, ICC;
关键字: Anti VEGF, bevacizum;
卡梅德生物科技(天津)有限公司作为国家级高新技术企业,专注于为全球科学家和研究机构提供天然蛋白提取与发酵、重组蛋白定制表达服务,单、多克隆抗体开发,噬菌体文库构建与筛选服务;同时,基于我公司成熟的五大核心技术服务平台,成功研发了众多用于科学研究的重组蛋白、抗体、抗体药物靶点蛋白、工业酶、诊断原料等相关试剂。